Dimensional Fund Advisors
LEXX icon

Dimensional Fund Advisors’s Lexaria Bioscience LEXX Stock Holding History

Dimensional Fund Advisors’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,268
Closed -$41.5K – 3499
2023
Q1 		$41.5K Hold
15,268
– – ﹤0.01% 3399
2022
Q4 		$37 Buy
15,268
+4
+0% +$10 ﹤0.01% 3422
2022
Q3 		$37K Buy
+15,264
New +$43.5K ﹤0.01% 3433

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

Dimensional Fund Advisors's LEXX Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of Lexaria Bioscience (LEXX) in Q2 2023, closing a stake of 15,268 shares — an estimated $41.5K sold.

Dimensional Fund Advisors first reported a position in LEXX in Q3 2022 and held it in 3 quarters. The position peaked at $41.5K in Q1 2023. 14 funds tracked by Wall St. Rank hold LEXX as of Q2 2023.

  • Dimensional Fund Advisors reported no remaining Lexaria Bioscience position as of Q2 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 15,268 Lexaria Bioscience shares in Q2 2023, an estimated $41.5K.
  • Dimensional Fund Advisors first reported a position in Lexaria Bioscience in Q3 2022 and held it in 3 quarters.
  • Dimensional Fund Advisors's Lexaria Bioscience position peaked at $41.5K in Q1 2023.
  • 14 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.